Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. - Wikidata - wikimedia - TriplyDB

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

http://www.wikidata.org/entity/Q37066550

about

Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound Drugs Recent advances in lymphatic targeted drug delivery system for tumor metastasis Liposomal delivery systems for intestinal lymphatic drug transport Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement Accurate sequential detection of primary tumor and metastatic lymphatics using a temperature-induced phase transition nanoparticulate system Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications Emulsomes meet S-layer proteins: an emerging targeted drug delivery system.The lymphatic system and pancreatic cancer.Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.microRNAs in the Lymphatic Endothelium: Master Regulators of Lineage Plasticity and Inflammation.Pulmonary Administration of Soluble Antigen Arrays Is Superior to Antigen in Treatment of Experimental Autoimmune Encephalomyelitis.Route and Type of Formulation Administered Influences the Absorption and Disposition of Vitamin B12 Levels in Serum.Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics.Tanshinol borneol ester on nanostructured lipid carriers has longer brain and systemic effector retention and better antioxidant activity in vivo.Lyophilized Hybrid Nanostructured Lipid Carriers to Enhance the Cellular Uptake of Verapamil: Statistical Optimization and In Vitro Evaluation

P2860

Q26741823-072E2256-1318-4B17-B33B-80ECA4AA9541 Q27005580-3220EF2C-BB40-432C-9845-BA1E37B183BE Q28067324-79BD7ACC-EB60-4460-B5F3-AA9934373418 Q30406598-A9867E69-D036-4213-B73C-D835A60136B2 Q33800703-E57D6BB0-CAFF-437D-818C-436C59F6E32F Q36408352-384D8DEC-5D84-4887-A8C6-71999543FA58 Q38361935-EFC7D2E9-78A5-42FF-8304-2E9B4744E0D8 Q38689578-0B5FA16E-68F9-4740-8DE9-386A450BFE93 Q38862706-580A2D20-D30A-4B89-81CD-672546546620 Q39148619-D4FD4C58-E4AF-40F5-921A-0EAD6F171ABC Q48008689-290B5C7A-3EC5-4556-92DD-48096F3AF82A Q48182671-2ECD0325-175E-4876-AAC9-3CFC10020AD8 Q54936269-DF5BA2AC-0239-44DE-B5C3-8714B274A9D8 Q55003285-00A7DB16-8F7F-40CB-851D-AF2DA4826CB9 Q57464672-E7A70748-E247-442D-9B6D-C45A6C820319

P2860

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

http://www.wikidata.org/entity/Q37066550

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

@en

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

@nl

type

label

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

@en

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

@nl

prefLabel

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

@en

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

@nl

P1433

Q37066550-66C5B524-9AD8-42A7-B9B9-B0716D9C1AF0

P1476

Q37066550-8525424B-CD28-4B82-BA3B-12B6A08AEDF0

P2093

Q37066550-51B2C8B5-5173-41D6-A5D6-9DCFDC31EBE5

Q37066550-893F42CA-95E7-4845-BEAD-55473CC27670

Q37066550-CA9B8940-C5A8-4C32-8877-3D7006D56FF3

Q37066550-F626F6D4-97FE-4600-BE0F-FFEB1C58541B

P2860

Q37066550-0139AC80-306C-460E-ADE1-D5FEF8183C13

Q37066550-03886DF3-B148-4EAA-92B6-7AE6C153E132

Q37066550-0CFC0841-9870-453D-A0B0-9ACCD01EB761

Q37066550-11A7543E-C841-4909-931B-A1FB8B1E31E7

Q37066550-1A42418C-1611-44CD-A0E4-139108568011

Q37066550-1B2C98C6-282E-4E2A-951D-FBD3018CE4FB

Q37066550-1B823B99-4FD5-4520-9481-61572E2E3331

Q37066550-1D8286D9-BC80-4BCA-B956-31D70610FC06

Q37066550-2409BEBD-A9EF-43E4-8566-8E728C8F1271

Q37066550-26018DFA-2E6F-46F1-975B-7DC99E9B98D2

P304

Q37066550-DDCF9BFD-076A-438A-B106-CB32F04FE0A4

P31

Q37066550-0FD5C0A9-BE3F-4AE3-A900-D9BFD6EB31A5

Q37066550-5A523548-DA7F-40EA-B8AA-48CDF4412EB7

P356

Q37066550-0F05D042-D9A3-4F43-9D52-ADD20870D505

P407

Q37066550-DF11FE60-936B-429E-A8D3-E0051EC68D9F

P478

Q37066550-D401C16C-AC37-460F-BA51-F388B9F97939

P577

Q37066550-DBCF943F-9149-4F10-AE70-3C2FDC665470

P5875

Q37066550-7896E7D8-B69C-46D6-BA76-5F89742D07F4

P698

Q37066550-AD8AE429-D022-44B7-BE5B-876738AA0055

P921

Q37066550-8A4212B6-97DF-4FE9-9DCE-33673C609E08

Q37066550-ACD11D14-FE76-459C-9E56-BC12D4C5BCA6

Q37066550-C4112926-A569-487E-A225-8354AEC99F66

Q37066550-E6E77E61-1917-42C0-A8AF-E0021FFF11AB

P932

Q37066550-A65392BA-92DA-4871-B90C-F69063B4556B

P356

P1433

International Journal of Nanomedicine

P1476

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

@en

P2093

Arshad Ali Khan

http://www.w3.org/2001/XMLSchema#string

Jahanzeb Mudassir

http://www.w3.org/2001/XMLSchema#string

Noratiqah Mohtar

http://www.w3.org/2001/XMLSchema#string

Yusrida Darwis

http://www.w3.org/2001/XMLSchema#string

P2860

Supramicron-sized particle clearance from alveoli: route and kinetics

Dissemination and growth of cancer cells in metastatic sites

Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.

Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.

Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure.

Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.

Novel approaches to the treatment of small-cell lung cancer.

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

The lymph node as a bridgehead in the metastatic dissemination of tumors.

P304

2733-2744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S41521

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255707616

http://www.w3.org/2001/XMLSchema#string

P698

23926431

http://www.w3.org/2001/XMLSchema#string

P921

manufactured product

hemic and immune systems

P932

3732201

http://www.w3.org/2001/XMLSchema#string